Understanding Familial Cold Autoinflammatory Syndrome (FCAS)

Familial Cold Autoinflammatory Syndrome (FCAS), also known as familial cold urticaria, is a rare genetic disorder characterized by episodes of rash, fever, joint pain, and fatigue triggered by exposure to cold temperatures. It is the mildest form of cryopyrin-associated periodic syndromes (CAPS), a group of autoinflammatory disorders caused by mutations in the NLRP3 gene.


Cryopyrin-associated periodic syndromes (CAPS) are a group of rare, inherited autoinflammatory disorders caused by mutations in the NLRP3 gene, leading to excessive production of interleukin-1β (IL-1β), a protein that plays a key role in the inflammatory response.


Cryopyrin-associated periodic syndromes (CAPS) encompasses three main conditions:

  • Familial Cold Autoinflammatory Syndrome (FCAS)
  • Muckle-Wells Syndrome (MWS) 
  • Neonatal-Onset Multisystem Inflammatory Disease (NOMID)/Chronic Infantile Neurological, Cutaneous, and Articular Syndrome (CINCA)

These conditions share common features such as recurrent episodes of fever, rash, joint pain, and systemic inflammation, but vary in severity and specific symptoms.


Learn more about CAPS

AiArthritis Disease Symptoms

AiArthritis diseases share common features such as flares, where symptoms worsen for hours to months, and improvements with physical activity, while rest can make symptoms worse. Genetic predisposition or mutations can lead to these conditions running in families, and uncontrolled inflammation often results in comorbidities, affecting 70% of patients.


Key symptoms include:


  • Severe fatigue that persists despite rest or stimulants
  • Brain fog, making concentration difficult
  • Flu-like sensations like nausea and muscle weakness
  • Low-grade fevers (higher in autoinflammatory diseases)
  • Joint stiffness, especially in the morning or after long periods of inactivity
  • Sudden, shifting joint pain that starts and stops abruptly


Symptoms of Familial Cold Autoinflammatory Syndrome (FCAS)

Symptoms of FCAS typically appear within the first few months of life, with the average age of onset being around 47 days. Common symptoms include:


  • Rash: Episodes of urticaria (hives) that appear within hours of cold exposure.
  • Fever: Episodes of fever that usually last less than 24 hours.
  • Joint Pain: Arthralgias (joint pain) and swelling.
  • Fatigue: Generalized fatigue and malaise during episodes.
  • Other Symptoms: Headache, conjunctivitis, and eye pain.


Discover More Of Our Resources

Submit Your Rant

Make your voice heard with AiArthritis RANT! Raise awareness, share your perspective, and help drive meaningful change in the autoimmune arthritis community. Join the movement now.

Patient Journey

Navigate every phase of life with autoimmune and autoinflammatory arthritis through the AiArthritis Patient Journey! From diagnosis to daily living, discover empowering tools, resources, and insights crafted to support you at every step.

AiArthritis Voices 360 Talk Show

Dive into the AiArthritis Voices 360 Talk Show, where patient leaders, medical experts, and advocates join forces to discuss life with autoimmune and autoinflammatory arthritis. Don't miss these candid and empowering conversations!


Diagnosing Familial Cold Autoinflammatory Syndrome (FCAS)

Familial Cold Autoinflammatory Syndrome (FCAS) typically presents in infancy or early childhood, often within the first few months of life. However, in very rare cases, it might be diagnosed later in life if symptoms are mild or if the disease is not recognized initially. Late-onset cases can present diagnostic challenges, as symptoms might be less pronounced or resemble other conditions. Despite this, it is unusual for FCAS to first appear in adulthood.


Diagnosis is based on clinical features and confirmed by genetic testing for mutations in the NLRP3 gene. A detailed medical history and physical examination are essential for identifying the characteristic symptoms and triggers.

Treatment of Familial Cold Autoinflammatory Syndrome (FCAS) 

The primary treatment for FCAS involves anti-IL-1 therapy, such as anakinra, which blocks the activity of IL-1β and helps reduce inflammation.


Other treatments include:


  • Canakinumab: Another IL-1β inhibitor used for patients who do not respond to anakinra.
  • Rilonacept: A fusion protein that inhibits IL-1β.
  • Lifestyle Modifications: Avoiding cold exposure and wearing protective clothing to minimize symptoms.
  • Supportive Care: Use of nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids to manage symptoms during acute episodes.


Who Treats Familial Cold Autoinflammatory Syndrome (FCAS)


Familial Cold Autoinflammatory Syndrome (FCAS) is typically managed by a multidisciplinary team of specialists, including rheumatologists, dermatologists, immunologists, and geneticists. These healthcare providers work together to diagnose, treat, and monitor the condition, ensuring comprehensive care for affected individuals.


With early diagnosis and appropriate treatment, individuals with FCAS can lead relatively normal lives. Regular monitoring and management of symptoms are essential to prevent complications and improve quality of life.


Familial Cold Autoinflammatory Syndrome (FCAS) is a rare but manageable condition that requires a multidisciplinary approach for effective treatment. Advances in understanding the genetic basis and treatment options have significantly improved outcomes for affected individuals. Continued research and awareness are crucial for further enhancing the care and quality of life for patients with FCAS.

Related Blog Posts

Three photos of a smiling man at an awareness event, holding a sign supporting rheumatoid arthritis awareness.
May 19, 2026
Read Franklin’s powerful lived experience with rheumatoid arthritis, from delayed diagnosis and invisible symptoms to resilience, adaptation, and finding strength through chronic illness.
Three-panel collage of people meeting, posing outdoors by the Capitol, and smiling at an indoor ceremony
May 18, 2026
Read Judy Nagy’s powerful lived experience with rheumatoid arthritis, from diagnosis and treatment to patient advocacy, resilience, and supporting others with chronic illness.
Bowl of oatmeal and blueberries for anti-inflammatory diet
March 7, 2026
Stuck on what to eat with inflammation in mind? 5 quick, easy breakfast ideas you can start tomorrow morning, no special ingredients needed.
Show More
IV drip bag hanging on a stand in a softly lit hospital room
May 30, 2026
Explore the latest discussion on early treatment for rheumatoid arthritis and what current research reveals about diagnosis, intervention, and long-term patient outcomes.
Woman in a white blazer seated at a vanity, holding a makeup mirror in a softly lit room.
May 30, 2026
Discover the latest research on rheumatoid arthritis, including insights into disease risk, the importance of early treatment, and the connection between RA and lung disease.
Person seated on a chair, clutching a glowing red knee in pain
May 29, 2026
Explore what emerging research is teaching us about difficult-to-treat and poly-refractory rheumatoid arthritis, including the challenges patients face when treatments stop working and the search for more personalized approaches to care.
Older man using a tablet at a desk in a bright home office
May 29, 2026
Learn about VEXAS syndrome, a newly identified inflammatory condition linked to immune system dysfunction, and why greater awareness may help patients with complex or overlapping AiArthritis disease symptoms find answers sooner.
More Posts